Skip to main content

View full-text article in PMC

. 2007 Jun 14;13(22):3071–3079. doi: 10.3748/wjg.v13.i22.3071

Table 3.

Effects of MLN64 recombinant adenoviral infection on hepatic cholesterol levels, biliary bile flow, and lipid secretion (mean ± SE)

		Hepatic cholesterol			Biliary lipid secretion
		Unesterified	Ester	Bile flow	Cholesterol	Bile salts	Phospholipids
Group	Liver weight	(mg/g liver weight)	(mg/g liver weight)	(μL/min/100 g body weight)	(nmol/min/100 g body weight)	(nmol/min/100 g body weight)	(nmol/min/100 g body weight)
Ad.E1Δ	1.32 ± 0.04 (n = 11)	1.97 ± 0.08	0.20 ± 0.08	9.43 ± 0.76 (n = 8)	2.75 ± 0.33	254.1 ± 34.2	84.25 ± 5.5
Ad.MLN64	1.14 ± 0.04 (n = 16)^a	2.38 ± 0.08^a	0.21 ± 0.07	4.14 ± 0.61^a	1.38 ± 0.19^a	308.5 ± 45.4	54.64 ± 13.5

Measurements were performed in six mice in each experimental group, except for liver weight and bile flow as indicated.

^a

P < 0.05 vs Ad.E1Δ-infected mice.